MBX8025 is primarily utilized in the field of medical research, particularly in the study of metabolic disorders such as hyperlipidemia, atherosclerosis, and insulin resistance. It is often investigated for its potential role in modulating lipid metabolism as a selective PPARδ agonist, which makes it a candidate for therapeutic applications in conditions like hyperlipidemia and atherosclerosis. Researchers are exploring its efficacy in reducing cholesterol levels and improving overall cardiovascular health. Additionally, MBX8025 is being studied for its anti-inflammatory properties, which could be beneficial in managing chronic inflammatory diseases. Its application extends to preclinical trials where its safety and effectiveness are evaluated for potential use in human medicine.